Although the number of patients with SMARCA4 alterations in our cohort is small, our results support the earlier observations that SMARCA4 alterations are indicators of poor survival in NSCLC [31], [32], [33], [34]. The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.